Filing Details
- Accession Number:
- 0001209191-23-020781
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-03-23 16:50:07
- Reporting Period:
- 2023-03-08
- Accepted Time:
- 2023-03-23 16:50:07
- Original Submission Date:
- 2023-03-10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1476151 | A Enrique Conterno | C/O Fibrogen, Inc. 409 Illinois Street San Francisco CA 94158 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-10 | 19,489 | $20.20 | 384,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.
Billionaire Hedge Funds
